Annual Shareholders Equity
$927.92 M
+$206.42 M+28.61%
December 31, 2023
Summary
- As of February 8, 2025, XENE annual stockholders equity is $927.92 million, with the most recent change of +$206.42 million (+28.61%) on December 31, 2023.
- During the last 3 years, XENE annual shareholders equity has risen by +$756.57 million (+441.52%).
- XENE annual shareholders equity is now at all-time high.
Performance
XENE Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$797.81 M
-$46.24 M-5.48%
September 30, 2024
Summary
- As of February 8, 2025, XENE quarterly stockholders equity is $797.81 million, with the most recent change of -$46.24 million (-5.48%) on September 30, 2024.
- Over the past year, XENE quarterly shareholders equity has dropped by -$46.24 million (-5.48%).
- XENE quarterly shareholders equity is now -14.02% below its all-time high of $927.92 million, reached on December 31, 2023.
Performance
XENE Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
XENE Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +28.6% | -5.5% |
| 3 y3 years | +441.5% | +23.4% |
| 5 y5 years | +798.3% | +23.4% |
XENE Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +68.7% | -14.0% | +47.2% |
| 5 y | 5-year | at high | +908.9% | -14.0% | +767.4% |
| alltime | all time | at high | +7251.0% | -14.0% | +3208.2% |
Xenon Pharmaceuticals Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $797.81 M(-5.5%) |
| Jun 2024 | - | $844.05 M(-4.9%) |
| Mar 2024 | - | $887.70 M(-4.3%) |
| Dec 2023 | $927.92 M(+28.6%) | $927.92 M(+45.8%) |
| Sep 2023 | - | $636.59 M(-1.5%) |
| Jun 2023 | - | $646.46 M(-5.9%) |
| Mar 2023 | - | $686.94 M(-4.8%) |
| Dec 2022 | $721.50 M(+31.2%) | $721.50 M(-4.2%) |
| Sep 2022 | - | $753.12 M(-4.2%) |
| Jun 2022 | - | $785.79 M(+45.0%) |
| Mar 2022 | - | $541.85 M(-1.5%) |
| Dec 2021 | $550.03 M(+221.0%) | $550.03 M(+121.0%) |
| Sep 2021 | - | $248.94 M(-3.1%) |
| Jun 2021 | - | $256.98 M(-7.0%) |
| Mar 2021 | - | $276.28 M(+61.2%) |
| Dec 2020 | $171.35 M(+86.3%) | $171.35 M(-5.9%) |
| Sep 2020 | - | $182.02 M(-3.8%) |
| Jun 2020 | - | $189.30 M(+0.7%) |
| Mar 2020 | - | $187.98 M(+104.4%) |
| Dec 2019 | $91.98 M | $91.98 M(+23.4%) |
| Sep 2019 | - | $74.56 M(-9.9%) |
| Jun 2019 | - | $82.79 M(-10.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | $92.31 M(-10.6%) |
| Dec 2018 | $103.30 M(+187.5%) | $103.30 M(-7.1%) |
| Sep 2018 | - | $111.16 M(+119.6%) |
| Jun 2018 | - | $50.62 M(+77.6%) |
| Mar 2018 | - | $28.50 M(-20.7%) |
| Dec 2017 | $35.93 M(-43.8%) | $35.93 M(-17.0%) |
| Sep 2017 | - | $43.30 M(-14.2%) |
| Jun 2017 | - | $50.45 M(-11.8%) |
| Mar 2017 | - | $57.20 M(-10.5%) |
| Dec 2016 | $63.90 M(+4.7%) | $63.90 M(-7.8%) |
| Sep 2016 | - | $69.31 M(+31.6%) |
| Jun 2016 | - | $52.66 M(-9.5%) |
| Mar 2016 | - | $58.16 M(-4.7%) |
| Dec 2015 | $61.03 M(-16.1%) | $61.03 M(-5.3%) |
| Sep 2015 | - | $64.46 M(+0.2%) |
| Jun 2015 | - | $64.35 M(-6.7%) |
| Mar 2015 | - | $68.97 M(-5.2%) |
| Dec 2014 | $72.78 M(+201.8%) | $72.78 M(+108.1%) |
| Sep 2014 | - | $34.98 M(+29.0%) |
| Jun 2014 | - | $27.11 M(+12.4%) |
| Dec 2013 | $24.12 M(+91.0%) | $24.12 M |
| Dec 2012 | $12.62 M | - |
FAQ
- What is Xenon Pharmaceuticals annual stockholders equity?
- What is the all time high annual shareholders equity for Xenon Pharmaceuticals?
- What is Xenon Pharmaceuticals annual shareholders equity year-on-year change?
- What is Xenon Pharmaceuticals quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Xenon Pharmaceuticals?
- What is Xenon Pharmaceuticals quarterly shareholders equity year-on-year change?
What is Xenon Pharmaceuticals annual stockholders equity?
The current annual shareholders equity of XENE is $927.92 M
What is the all time high annual shareholders equity for Xenon Pharmaceuticals?
Xenon Pharmaceuticals all-time high annual stockholders equity is $927.92 M
What is Xenon Pharmaceuticals annual shareholders equity year-on-year change?
Over the past year, XENE annual stockholders equity has changed by +$206.42 M (+28.61%)
What is Xenon Pharmaceuticals quarterly stockholders equity?
The current quarterly shareholders equity of XENE is $797.81 M
What is the all time high quarterly shareholders equity for Xenon Pharmaceuticals?
Xenon Pharmaceuticals all-time high quarterly stockholders equity is $927.92 M
What is Xenon Pharmaceuticals quarterly shareholders equity year-on-year change?
Over the past year, XENE quarterly stockholders equity has changed by -$46.24 M (-5.48%)